FDA approves pill with sensor that digitally tracks ingestion

For the past several years, we had heard about the sensor technology and patch developed by Proteus Digital Health. The FDA just approved the first pill that integrates this technology into Abilify, a drug used to treat schizophrenia.

Abilify MyCite (aripiprazole tablets with sensor) has an ingestible sensor embedded in the pill that records that the medication was taken. The product is approved for the treatment of schizophrenia, acute treatment of manic and mixed episodes associated with bipolar I disorder and for use as an add-on treatment for depression in adults.

FDA announcement.